Fortrea Holdings Inc. (FTRE) vs Viridian Therapeutics, Inc. (VRDN)

A side-by-side comparison of Fortrea Holdings Inc. and Viridian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FTRE vs VRDN

growth of $100 · dividends reinvested · last 3y
FTRE -34.0% (-12.9%/yr)VRDN -31.8% (-12.0%/yr)VRDN compounded faster over this window
50100Start $100202420252026$66$68
FTRE VRDN

FTRE vs VRDN: by the numbers

  • •VRDN is the larger company ($2.06B vs $1.98B market cap).
  • •Both run net losses; FTRE's is the smaller (-3.18% vs -544.06% net margin).
  • •VRDN grew revenue faster over the past five years (93.92% vs 1.09% CAGR).

Metrics side by side

Valuation

MetricFTREVRDN
Forward P/E24.71N/A
P/S ratio0.7429.02
P/B ratio3.773.66
EV / EBITDA32.76N/A
FCF yield7.62%N/A

Profitability

MetricFTREVRDN
Gross margin17.11%99.55%
Operating margin0.41%-512.91%
Net margin-3.18%-544.06%
ROE-16.25%-58.45%
ROIC0.62%-39.18%

Growth (annualized)

MetricFTREVRDN
Revenue CAGR (5Y)1.09%93.92%
FCF CAGR (5Y)-12.98%N/A
Total return CAGR (5Y)N/A1.64%

Frequently asked

Which has grown faster, FTRE or VRDN?
Over the past five years, VRDN grew revenue faster — FTRE at a 1.09% CAGR versus VRDN at 93.92%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.